0.0472
-0.0020
(-4.07%)
At close: April 14 at 7:31:04 PM GMT+2
Loading Chart for 3KF.BE
- Previous Close
0.0492 - Open
0.0000 - Bid --
- Ask --
- Day's Range
0.0000 - 0.0000 - 52 Week Range
0.0000 - 0.0570 - Volume
0 - Avg. Volume
686 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 3KF.BE
View MorePerformance Overview: 3KF.BE
Trailing total returns as of 4/14/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .
YTD Return
3KF.BE
81.54%
S&P/TSX Composite index (^GSPTSE)
3.06%
1-Year Return
3KF.BE
23.56%
S&P/TSX Composite index (^GSPTSE)
8.98%
3-Year Return
3KF.BE
58.38%
S&P/TSX Composite index (^GSPTSE)
9.20%
5-Year Return
3KF.BE
78.35%
S&P/TSX Composite index (^GSPTSE)
67.39%
Compare To: 3KF.BE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.0472
-4.07%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.0400
+0.97%
Mkt Cap 139.13M
Industry Drug Manufacturers—Specialty & Generic
4.2500
-0.70%
Mkt Cap 233.257M
Industry Drug Manufacturers—Specialty & Generic
1.0300
+9.57%
Mkt Cap 169.982M
Industry Drug Manufacturers—Specialty & Generic
0.4868
-0.12%
Mkt Cap 485.878M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 3KF.BE
View MoreValuation Measures
As of 4/11/2025
Market Cap
65.38M
Enterprise Value
97.20M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.76
Price/Book (mrq)
0.86
Enterprise Value/Revenue
1.25
Enterprise Value/EBITDA
6.26
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--